Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

During the Trading Day
4.32 -0.15 / -3.36%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.32 0.00 / 0.00%
 
Volume: 24.7K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$127.7M

Company Description

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases. The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobin A nephropathy, or IgAN, lupus nephritis, vasculitis, rheumatoid arthritis, idiopathic thrombocytopenia purpura, and others. Anthera Pharmaceuticals was founded by Paul F. Truex on September 9, 2004 and is headquartered in Hayward, CA.

Contact Information

Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard
Hayward California 94545
P:(510) 856-5600
Investor Relations:
(510) 856-5586

Employees

Shareholders

Other institutional27.07%
Mutual fund holders11.21%
Individual stakeholders0.86%

Top Executives

Paul F. TruexPresident, Chief Executive Officer & Director
May LiuCAO, Senior VP-Finance & Administration
Colin HislopChief Medical Officer & Senior Vice President
Debra A. OdinkChief Technology Officer & Senior Vice President
Klara A. Dickinson-EasonChief Regulatory Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account